IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Atle Fund Management AB

Q2 2016 Holdings

Filed 2016-07-26 | 18 holdings | $34.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Anika Therapeutics Inc(ANIK)COM035255108$22.1M412,58863.9%
Charles RIV Labs Intl Inc(CRL)COM159864107$12.3M149,61235.6%
GNC Hldgs IncCOM CL A36191G107$16.6K681,9550.0%
Amag Pharmaceuticals Inc(AMAG)COM00163U106$16.1K671,5850.0%
Supernus Pharmaceuticals Inc(SUPN)COM868459108$13.4K657,5330.0%
Triple-S Mgmt Corp(GTS)CL B896749108$13.0K532,8760.0%
Merck & Co Inc(MRK)COM58933Y105$12.9K224,1000.0%
Amerisourcebergen Corp(COR)COM03073E105$12.7K160,0000.0%
FEI CoCOM30241L109$12.7K118,6090.0%
Taro Pharmaceutical Inds LTDSHSM8737E108$12.6K86,2050.0%
Cardinal Health Inc(CAH)COM14149Y108$12.5K160,0000.0%
Anthem Inc(ELV)COM036752103$12.3K93,9000.0%
Lifepoint Health IncCOM53219L109$12.1K185,8510.0%
Concordia Intl CorpCOM20653P102$11.7K543,0000.0%
Inc Resh Hldgs IncCL A45329R109$10.9K286,2700.0%
Insys Therapeutics Inc NewCOM NEW45824V209$10.2K788,1750.0%
Orasure Technologies Inc(OSUR)COM68554V108$2.8K475,7710.0%
Immucell Corp(ICCC)COM PAR $0.10452525306$1.2K168,3230.0%